English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Saturday, April 20, 2024
Phish Live at Sphere: Moment Factory Harnesses Sphere's Next-Generation Technologies to Reimagine Concert Experience
Monday, April 15, 2024
Seamless for Science: Revolutionizing Literature Reviews with Advanced AI and Real Database Access
BLUETTI Leads the Charge Towards Greener Living this Earth Day 2024
Friday, April 12, 2024
Tau Unveils Groundbreaking Research in Logical Languages to Transform Software Development
Thursday, April 11, 2024
Hack The Box Redefines Cybersecurity Performance, Setting New Standards in the Cyber Readiness of Organizations
Tuesday, April 9, 2024
Chiron AS in Trondheim, Norway, Has Developed The World's First Commercial Microplastic Reference Materials
Exosens Adds Innovative Photon Counting System, LINCam, to Its Portfolio of Single Photon Sensitive Detectors
Thursday, April 4, 2024
World Hepatitis Summit 2024 Convenes in Lisbon
New Beginnings: Pioneers of AI Art, London Exhibition (11 April 2024)
Wednesday, April 3, 2024
Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575